Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT06099509 Recruiting - Clinical trials for Gestational Diabetes

Self-Administered 2-Hour Oral Glucose Tolerance Test

Start date: November 2, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to evaluate whether self-administered postpartum diabetes screening tests in patients with gestational diabetes improves screening completion rates. The primary question it aims to answer is: 1. Does a self-administered 75-gram oral glucose tolerance test with virtual follow-up visit increase the rate of postpartum diabetes screening within 12 weeks of delivery?

NCT ID: NCT06099366 Recruiting - Clinical trials for Lymphoblastic Leukemia in Children

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Start date: March 5, 2024
Phase: Phase 2
Study type: Interventional

Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for standard risk acute lymphoblastic leukemia in children and adolescents.

NCT ID: NCT06099288 Recruiting - Diet, Healthy Clinical Trials

Strong Families Start at Home/Familias Fuertes Comienzan en Casa

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the ability of a home-based parental nutrition intervention to improve diet quality in preschool aged children within low-income, Latinx/Hispanic families. The main questions it aims to answer are: - Does this enhanced intervention change children's diet quality? - Does this enhanced intervention change parental feeding practices? - Does this enhanced intervention change the availability of healthy foods in the home? Participants will: - Work with a support coach - Have a home visit with a support coach once a month, for three months - Have a phone call with a support coach once a month, for three months - Receive written materials and text messages over the six months Researchers will compare a control group receiving different written materials and messages to see if the enhanced intervention changes diet quality in children.

NCT ID: NCT06098729 Recruiting - Type 1 Diabetes Clinical Trials

Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes

Start date: November 2, 2023
Phase: N/A
Study type: Interventional

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently.

NCT ID: NCT06098508 Recruiting - Clinical trials for Hemiplegic Shoulder Pain

Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients

Start date: June 2024
Phase: N/A
Study type: Interventional

This study assesses the feasibility and safety of performing osteopathic manual treatment (OMT) for hemiplegic shoulder pain in stroke patients. This study's participants will be adults with a first-time stroke diagnosis in the past 5 years and shoulder pain on the same side affected by stroke. Eligible participants will be placed on study for approximately 6 weeks and given either OMT or a sham treatment each week.

NCT ID: NCT06097468 Recruiting - Clinical trials for Oral Cavity Squamous Cell Carcinoma

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Start date: February 2, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a study of oral nisin administration in patients with OSCC who are undergoing complete surgical resection surgery with or without adjuvant radiation/chemoradiation as part of their routine care at the University of California, San Francisco (UCSF).

NCT ID: NCT06097312 Recruiting - Clinical trials for Vaccine Exposure During Pregnancy

PREHEVBRIO Pregnancy Outcomes Registry

Start date: November 30, 2023
Phase:
Study type: Observational

The registry is an observational surveillance program designed to recruit and encourage participation of women who were exposed to PREHEVBRIO® hepatitis B vaccine during pregnancy and to collect and analyze information related to post-exposure pregnancy and fetal and neonatal outcomes. The objective of the Registry is to monitor and evaluate all received reports of PREHEVBRIO® vaccine exposure within 28 days prior to conception or at any time during pregnancy and delivery, as well as maternal, obstetrical, pregnancy, fetal and neonatal outcomes. This registry is primarily descriptive and designed to detect potential safety signals rather than test hypotheses.

NCT ID: NCT06096844 Recruiting - Clinical trials for Stage IV Lung Cancer AJCC v8

Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Start date: November 11, 2024
Phase: Phase 3
Study type: Interventional

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.

NCT ID: NCT06096376 Recruiting - Clinical trials for Acute Hypoxemic Respiratory Failure

Predictors of HFNC Failure in Patients With AHRF Using Diaphragm Ultrasound

ULTRAFLOW
Start date: April 28, 2023
Phase:
Study type: Observational [Patient Registry]

Ultrasound of the diaphragm is an easily reproducible bedside tool that provides a non-invasive measurement of inspiratory muscle function and respiratory efficiency. The diaphragmatic thickness correlates with the strength and muscle shortening and is reflective of its contribution to the respiratory workload. Diaphragm thickening fraction (DTF) has been shown to be predictive of extubation failure in ventilated patients. However, whether measurements of DTF are predictive of high flow nasal cannula (HFNC) outcomes in patients with acute hypoxemic respiratory failure (AHRF) remains unknown. The objective of this study is to identify predictors of HFNC failure by diaphragm ultrasound and to compare its performance with the well-established ROX index.

NCT ID: NCT06096363 Recruiting - Clinical trials for Acute Hypoxemic Respiratory Failure

Predictors of HFNC Failure in Patients With AHRF Using Echocardiography Parameters

AHRF-ECHO
Start date: April 28, 2023
Phase:
Study type: Observational [Patient Registry]

Right ventricular dysfunction (RVD) and right ventricular-pulmonary arterial (RV-PA) uncoupling detected by transthoracic echocardiography (TTE) in acute respiratory distress syndrome (ARDS) are associated with poor survival. Early detection of RVD and RV-PA uncoupling in patients with acute hypoxemic respiratory failure (AHRF) may be indicative of worsening and decompensating pulmonary condition which may require escalation of respiratory support. The use of TTE parameters in predicting high-flow nasal cannula (HFNC) failure has not been previously studied. The objective of this study is to identify predictors of HFNC failure by TTE and to compare its performance with the well-established ROX index.